Seattle Times sues Microsoft and OpenAI, alleging they trained their AI on its journalism
Source: geekwire.com
The Seattle Times Co. sued Microsoft and OpenAI, alleging they scraped hundreds of thousands of its and Newsday’s articles (bypassing paywalls/ToS) to train AI models, seeking damages and destruction of training datasets/models. The suit also highlights prior/overlapping litigation, including a similar 2023 New York Times case where a DOJ brief argued publisher wins would stifle US AI development. Publicly disclosed licensing deals with other outlets reportedly exceed $300M for three deals, underscoring the legal and commercial overhang for AI training by major publishers.
Analysis
This is less about headline damages and more about who captures the tollbooth on model inputs. If courts keep pushing toward provenance, opt-out, or retroactive licensing, the economics of frontier AI shift from one-time training capex to recurring content royalties, which compresses gross margins and slows the pace at which MSFT can roll new model families without legal friction. That matters more for narrative and multiple expansion than for near-term EPS, but the market tends to re-rate platform names when an input cost becomes structurally visible.
The cleaner beneficiaries are premium archives with negotiating leverage: NYT and ZD are not trading on this single suit, but they become more valuable as scarce data rights rather than ad-supported media. The second-order winner is any publisher with differentiated, searchable, enterprise-usable content; the loser set is broader than MSFT/OpenAI because every model provider now faces a higher probability that content owners demand paid access rather than free crawling. That creates a moat for licensed datasets and may advantage incumbents that can absorb legal spend.
Near term, the DOJ brief is a speed bump for plaintiffs, so the immediate price reaction in MSFT should be muted unless the case starts producing discovery risk or injunction language. Over 1-3 months, watch for settlement talks and whether more publishers file copycat claims; over 6-18 months, the key question is whether licensing becomes a standard operating expense or a one-off nuisance. The contrarian view is that consensus may be overestimating direct financial damage to MSFT and underestimating how quickly the ecosystem normalizes paid content deals, which would cap downside for MSFT while strengthening the bargaining power of large publishers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
Key Decisions for Investors
- Tactically underweight MSFT vs XLK/QQQ into legal-driven strength over the next 2-6 weeks; this is a multiple-risk call, not an earnings call, and should be sized modestly because direct P&L impact is likely low.
- Long NYT/ZD basket vs short MSFT on a 1-3 month relative-value basis if additional publisher suits or settlement chatter emerge; thesis is that scarce content rights monetize better than free training access. Falsify if Microsoft/OpenAI secure cheap umbrella licenses without margin pressure.
- Set an alert for any court order that limits dataset retention or expands discovery into training provenance; that would be the first catalyst for a deeper AI valuation reset and a trigger to add downside hedges on MSFT.
- Prefer call spreads on ZD or NYT only if there is concrete licensing-news flow; otherwise do not force a trade, because the equity impact is more about negotiation leverage than near-term revenue.
More News
- Here are the 3 big things we're watching in the stock market this week
- Jim Cramer: Why I am taking the other side of the trade that crushed the market Friday
- Microsoft reportedly quits Nscale’s UK data centre weeks before its IPO
- Data Centers Have a New PR Plan: Your Kid’s Field Trip
- The Bond Market Is Sending a Warning to Nvidia Shareholders
- These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AlphaSense Pricing: What Public Contract Data Shows in 2026
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market